Table 1.
Demographics and clinical data of the study groups.
| OHT Group (n = 57) |
Early POAG Group (n = 57) |
p | |
|---|---|---|---|
| Sex (male/female) | 23/34 | 22/35 | 1 ‡ |
| Age (years) | 65.71 ± 11.80 | 70.68 ± 11.81 | 0.127 |
| Right eye/Left eye | 28/29 | 25/32 | 0.782 ‡ |
| BCVA (decimal) | 0.95 ± 0.24 | 0.91 ± 0.46 | 0.210 |
| IOP (mmHg) | 18.74 ± 3.76 | 18.09 ± 3.64 | 0.352 |
| Vertical cupping | 0.35 ± 0.20 | 0.51 ± 0.26 | <0.001 |
| MD (dB) | −0.96 ± 0.51 | −3.39 ± 1.59 | 0.013 |
| PSD (dB) | 1.05 ± 0.52 | 3.62 ± 2.06 | 0.009 |
| Number of antiglaucoma eyedrops | 1.01 ± 0.86 | 1.46 ± 0.88 | 0.006 § |
The values represent mean ± standard deviation. Significant results are indicated in bold. ‡ Fisher test. § Mann–Whitney U test. The rest of the p values were obtained through an unpaired Student t-test. OHT = ocular hypertension; POAG = primary open-angle glaucoma; BCVA = best-corrected visual acuity; IOP = intraocular pressure; MD = mean deviation; PSD = pattern standard deviation.